Is Weight Gain Around the Middle Normal in Perimenopause?

Is Weight Gain Around the Middle Normal in Perimenopause?

Yes — for most women, some degree of central weight gain during perimenopause is physiologically normal. Declining estrogen shifts fat storage from the hips and thighs toward the abdomen, and metabolic rate drops alongside it. The main caveat: "normal" doesn't mean inevitable or untreatable. Women with well-managed blood sugar, stress hormones, and thyroid function often sidestep the worst of it.

---

Why Estrogen Decline Drives Belly Fat

Estrogen does far more than regulate your menstrual cycle. One of its lesser-known roles is directing where your body stores fat. During reproductive years, estrogen promotes peripheral fat storage — hips, thighs, and buttocks. As ovarian estrogen production falls in perimenopause, that preferential storage pattern reverses, and visceral fat accumulates around the abdomen and internal organs instead.

A large observational study from the Study of Women's Health Across the Nation (SWAN) followed over 3,000 women through the menopausal transition and found that waist circumference increased by an average of 2.1 cm even in women whose total body weight barely changed (Sternfeld et al., Menopause 2014; PMID: 24496083). This means the scale can look normal while your body composition is quietly shifting toward a metabolically riskier profile.

Visceral fat is not inert. It produces inflammatory cytokines including IL-6 and TNF-α, drives insulin resistance, and is independently associated with elevated cardiovascular risk — which is one reason cholesterol levels in perimenopause tend to worsen at the same time as the waistline expands. The two are biologically linked.

---

Insulin and Weight Gain: The Blood Sugar Connection

One of the most underappreciated drivers of midlife belly fat is worsening insulin sensitivity. Estrogen has direct insulin-sensitizing effects on muscle and fat tissue. As estrogen falls, insulin sensitivity declines — meaning your cells require more insulin to process the same amount of glucose. Higher circulating insulin signals the body to store energy as fat, preferentially in visceral depots.

A 2019 review in the journal Climacteric found that insulin resistance increases significantly during the menopausal transition independent of aging alone, suggesting estrogen withdrawal itself is a causal factor rather than just a bystander (Mauvais-Jarvis et al., Climacteric 2019; PMID: 31067122). Women who enter perimenopause with already-elevated fasting insulin are at the highest risk for accelerated central weight gain.

This is important context if you've had your fasting insulin checked: even mildly elevated values — say, above 8–10 µIU/mL — in a fasting state are worth addressing. For a deeper look at whether fasting insulin matters when your other metabolic markers look fine, see does fasting insulin matter if everything else is normal.

Practical dietary strategies that support insulin sensitivity during perimenopause include reducing refined carbohydrate load, prioritizing protein at each meal (which blunts postprandial glucose spikes), and ensuring adequate magnesium — a mineral that acts as a cofactor in over 300 enzymatic reactions, including glucose metabolism. Studies consistently show that magnesium insufficiency worsens insulin resistance (Barbagallo & Dominguez, Magnesium Research 2010; PMID: 20533872).

---

DHEA, Pregnenolone, and Weight Gain: The Adrenal Hormone Piece

As ovarian hormone production winds down, the adrenal glands are asked to compensate — producing DHEA (dehydroepiandrosterone) and its sulfate form DHEA-S as precursors for estrogen and testosterone synthesis. But adrenal reserve varies significantly between individuals, and when DHEA output falls alongside estrogen, the downstream effects include not just fatigue and low libido but altered body composition.

DHEA and its downstream androgen metabolites play a role in maintaining lean muscle mass and influencing fat distribution. Lower DHEA levels have been associated with increased visceral adiposity in several cross-sectional studies. Similarly, pregnenolone — often called the "mother hormone" because it sits at the top of the steroid hormone cascade — declines with age and stress, potentially reducing the substrate available for both cortisol and sex hormone production.

The relationship between these upstream hormones and weight is indirect but real: when DHEA-S falls, muscle-sparing androgens fall with it, making it harder to maintain the lean mass that keeps metabolic rate elevated. If you've recently had labs and are wondering about adrenal hormone status postpartum or in the perimenopausal window, understanding what a normal DHEA-S level looks like can help contextualize your results.

It's worth noting that DHEA and pregnenolone supplementation are not without complexity — excess DHEA can convert to estrogen or testosterone in unpredictable amounts depending on an individual's enzyme profile, which is why these are not candidates for generic over-the-counter use. Any consideration of supplemental DHEA or pregnenolone should follow lab-confirmed deficiency and be discussed with a healthcare provider.

---

The Thyroid-Weight Cycle in Perimenopause

Here is a pattern many perimenopausal women recognize immediately: take thyroid medication, lose weight, feel better, go slightly hyperthyroid. Lower the dose, gain weight, feel terrible, slip hypothyroid. Repeat endlessly.

This cycle isn't just frustrating — it reflects a genuine physiological instability during perimenopause. Estrogen affects thyroid-binding globulin (TBG) levels; as estrogen fluctuates, so does the amount of thyroid hormone available in its free, active form. A woman who was stable on a given levothyroxine dose for years may suddenly find that same dose produces symptoms of overreplacement as her estrogen drops, then find herself undertreated when she adjusts downward.

Subclinical hypothyroidism — TSH mildly elevated, free T4 still technically normal — is particularly common in perimenopausal women and contributes meaningfully to weight gain, fatigue, and low mood. A 2020 meta-analysis in Thyroid found that women with subclinical hypothyroidism had significantly higher body mass index and waist circumference than euthyroid controls (Ittermann et al., Thyroid 2020; PMID: 32019399). Even small impairments in thyroid function slow resting metabolic rate noticeably.

Supportive nutrients for thyroid function include selenium (as selenomethionine), iodine, zinc, and vitamin D. Selenium in particular is required for the conversion of T4 to the more active T3 form. If thyroid-related symptoms are present alongside perimenopausal weight gain, a comprehensive thyroid panel — including TSH, free T4, free T3, and thyroid antibodies — is worth requesting from your clinician.

---

Cortisol, Sleep, and the Stress-Belly Connection

Perimenopause is also a period of elevated cortisol reactivity. Night sweats disrupt sleep architecture, reducing slow-wave sleep — the stage most critical for growth hormone release and tissue repair. Poor sleep independently raises cortisol, which then promotes visceral fat accumulation through glucocorticoid receptors concentrated in abdominal adipose tissue.

The compounding effect is real: poor sleep → elevated cortisol → increased appetite (especially for calorie-dense foods) → impaired insulin sensitivity → more visceral fat. Research published in Obesity found that sleep duration below six hours was associated with significantly greater visceral fat deposition compared to seven to eight hours, independent of total caloric intake (Theorell-Haglöw et al., Obesity 2012; PMID: 22262163).

Addressing sleep quality is therefore a legitimate metabolic intervention, not just a comfort measure. Magnesium glycinate has modest but consistent evidence for improving sleep onset and sleep quality in adults with insufficient magnesium status. Ashwagandha (as KSM-66 at 600 mg daily) has been shown in double-blind trials to reduce cortisol by approximately 27% and improve self-reported sleep quality over 60 days (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). Both mechanisms are relevant when perimenopausal stress and poor sleep are fueling belly fat accumulation.

Anxiety often shadows the cortisol dysregulation of perimenopause as well. If you're experiencing mood and anxiety changes alongside weight shifts, is anxiety normal in perimenopause covers the hormonal underpinnings in detail.

---

What This Means for Your Formula

There is no single supplement that reverses perimenopausal central weight gain — any platform or product suggesting otherwise should be approached with skepticism. What evidence does support is a targeted approach that addresses the specific hormonal and metabolic disruptions driving the change in each individual.

Ones analyzes blood work, wearable data, and health history through its AI health practitioner to identify which of these mechanisms is most active for a given person — whether that's insulin resistance, cortisol dysregulation, thyroid insufficiency, or adrenal hormone decline. From that analysis, a personalized capsule formula is built from Ones' catalog of clinically validated ingredients.

For perimenopausal weight management, three ingredients frequently appear in Ones formulas depending on the individual's findings:

• Ashwagandha KSM-66 (600 mg): Clinically studied at this exact dose for cortisol reduction and sleep quality improvement — both directly relevant to visceral fat accumulation driven by HPA axis dysregulation.
• Magnesium Glycinate (from Ones' Magnesium Complex): Supports insulin sensitivity and sleep quality. Magnesium insufficiency is extremely common in perimenopausal women and worsens both glucose metabolism and cortisol regulation.
• Ones Adrenal Support Blend: A proprietary system blend designed to support adrenal resilience during periods of hormonal transition — relevant when DHEA output and stress hormone balance are contributing to body composition shifts.

Thyroid-supportive ingredients including selenomethionine and zinc are also available within Ones' catalog, calibrated to clinical ranges when lab findings indicate they are warranted.

---

Key Takeaways

• Midabdominal weight gain during perimenopause is physiologically normal — driven by declining estrogen, worsening insulin sensitivity, and shifts in adrenal and thyroid hormone balance.
• It's not inevitable. Women who address insulin sensitivity, manage cortisol, and support thyroid and adrenal function often experience significantly less central fat accumulation.
• Insulin resistance worsens as estrogen falls, making blood sugar management (dietary protein, fiber, magnesium, and exercise) one of the highest-leverage interventions available.
• DHEA and pregnenolone decline contributes to loss of lean mass and altered fat distribution; lab testing is essential before considering supplementation of these hormones.
• The thyroid-dose cycling many perimenopausal women experience reflects real TBG fluctuations as estrogen shifts — thyroid optimization should account for this dynamic.
• Sleep and cortisol are underrated drivers of belly fat in perimenopause; targeted support with KSM-66 ashwagandha and magnesium glycinate has clinical evidence behind both mechanisms.

---

Always consult a qualified healthcare provider before making changes to hormone therapies, thyroid medications, or starting new supplements.